Literature DB >> 32833945

Proteomic Analysis of Cell Lines and Primary Tumors in Pancreatic Cancer Identifies Proteins Expressed Only In Vitro and Only In Vivo.

Orla Coleman1, Michael Henry1, Fiona O'Neill1, Sandra Roche1, Niall Swan, Justin Geoghegan2, Kevin Conlon3, Gerard McVey4, Michael Moriarty, Paula Meleady, Martin Clynes.   

Abstract

OBJECTIVES: A limited repertoire of good pancreatic ductal adenocarcinoma (PDAC) models is one of the main barriers in developing effective new PDAC treatments. We aimed to characterize 6 commonly used PDAC cell lines and compare them with PDAC patient tumor samples using proteomics.
METHODS: Proteomic methods were used to generate an extensive catalog of proteins from 10 PDAC surgical specimens, 9 biopsies of adjacent normal tissue, and 6 PDAC cell lines. Protein lists were interrogated to determine what extent the proteome of the cell lines reflects the proteome of primary pancreatic tumors.
RESULTS: We identified 7973 proteins from the cell lines, 5680 proteins from the tumor tissues, and 4943 proteins from the adjacent normal tissues. We identified 324 proteins unique to the cell lines, some of which may play a role in survival of cells in culture. Conversely, a list of 63 proteins expressed only in the patient samples, whose expression is lost in culture, may place limitations on the degree to which these model systems reflect tumor biology in vivo.
CONCLUSIONS: Our work offers a catalog of proteins detected in each of the PDAC cell lines, providing a useful guide for researchers seeking model systems for PDAC functional studies.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32833945     DOI: 10.1097/MPA.0000000000001633

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  2 in total

1.  Neoplastic cell enrichment of tumor tissues using coring and laser microdissection for proteomic and genomic analyses of pancreatic ductal adenocarcinoma.

Authors:  Qing Kay Li; Yingwei Hu; Lijun Chen; Michael Schnaubelt; Daniel Cui Zhou; Yize Li; Rita Jui-Hsien Lu; Mathangi Thiagarajan; Galen Hostetter; Chelsea J Newton; Scott D Jewell; Gil Omenn; Ana I Robles; Mehdi Mesri; Oliver F Bathe; Bing Zhang; Li Ding; Ralph H Hruban; Daniel W Chan; Hui Zhang
Journal:  Clin Proteomics       Date:  2022-10-20       Impact factor: 5.000

Review 2.  Quantitative proteomics characterization of cancer biomarkers and treatment.

Authors:  Xiao-Li Yang; Yi Shi; Dan-Dan Zhang; Rui Xin; Jing Deng; Ting-Miao Wu; Hui-Min Wang; Pei-Yao Wang; Ji-Bin Liu; Wen Li; Yu-Shui Ma; Da Fu
Journal:  Mol Ther Oncolytics       Date:  2021-04-20       Impact factor: 7.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.